Evidence map›Paper›PMID 25096579›Full record

ArticleThe Journal of biological chemistry2014

Altered thiol chemistry in human amyotrophic lateral sclerosis-linked mutants of superoxide dismutase 1.

Carles Solsona, Thomas B Kahn, Carmen L Badilla, Cristina Álvarez-Zaldiernas, Juan Blasi, Julio M Fernandez, Jorge Alegre-Cebollada

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A mitochondrial superoxide theory for oxidative stress diseases and aging.Journal of clinical biochemistry and nutrition · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Carles SolsonaLaboratory of Cellular and Molecular Neurobiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine-Campus Bellvitge, University of Barcelona, Feixa Llarga s/n. Hospitalet de Llobregat, 08907 Barcelona, Spain,; Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de l'Hospitalet, 199-203, L'Hospitalet de Llobregat, Barcelona, 08908 Barcelona, Spain,. Electronic address: solsona@ub.edu.
Thomas B KahnDepartment of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, New York 10032,; Department of Biological Sciences, Columbia University, New York, New York 10027, and.
Carmen L BadillaDepartment of Biological Sciences, Columbia University, New York, New York 10027, and.
Cristina Álvarez-ZaldiernasLaboratory of Cellular and Molecular Neurobiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine-Campus Bellvitge, University of Barcelona, Feixa Llarga s/n. Hospitalet de Llobregat, 08907 Barcelona, Spain,; Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de l'Hospitalet, 199-203, L'Hospitalet de Llobregat, Barcelona, 08908 Barcelona, Spain.
Juan BlasiLaboratory of Cellular and Molecular Neurobiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine-Campus Bellvitge, University of Barcelona, Feixa Llarga s/n. Hospitalet de Llobregat, 08907 Barcelona, Spain,; Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de l'Hospitalet, 199-203, L'Hospitalet de Llobregat, Barcelona, 08908 Barcelona, Spain.
Julio M FernandezDepartment of Biological Sciences, Columbia University, New York, New York 10027, and.
Jorge Alegre-CebolladaDepartment of Biological Sciences, Columbia University, New York, New York 10027, and; Vascular Biology and Inflammation Department, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Cl. Melchor Fernández Almagro 3, 28029 Madrid, Spain.
Columbia University · USInstitut d'Investigació Biomédica de Bellvitge · ESBellvitge University Hospital · ESSpanish National Centre for Cardiovascular Research · ES

Funding

Single Molecule Studies of Titin ElasticityR01HL061228 · NHLBI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI FERNANDEZ, JULIO M · 1999 to 2017
$7.4M
TRAINING PROGRAM IN MOLECULAR BIOPHYSICST32GM008281 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PALMER, ARTHUR G · 1988 to 2017
$5.4M
Nanomechanics of the extracellular matrixR01HL066030 · NHLBI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI FERNANDEZ, JULIO M · 2001 to 2013
$5.0M
Bacterial Attachment under Mechanical PerturbationsK99AI106072 · NIAID · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ALEGRE-CEBOLLADA, JORGE · 2013 to 2013
$108k
NHLBI NIH HHS HL61228NHLBI NIH HHS HL66030NHLBI NIH HHS R01 HL061228NHLBI NIH HHS R01 HL066030NIAID NIH HHS AI106072NIGMS NIH HHS T32 GM008281NIGMS NIH HHS T32GM008281
6 · The paper itself

Abstract

Neurodegenerative diseases share a common characteristic, the presence of intracellular or extracellular deposits of protein aggregates in nervous tissues. Amyotrophic Lateral Sclerosis (ALS) is a severe and fatal neurodegenerative disorder, which affects preferentially motoneurons. Changes in the redox state of superoxide dismutase 1 (SOD1) are associated with the onset and development of familial forms of ALS. In human SOD1 (hSOD1), a conserved disulfide bond and two free cysteine residues can engage in anomalous thiol/disulfide exchange resulting in non-native disulfides, a hallmark of ALS that is related to protein misfolding and aggregation. Because of the many competing reaction pathways, traditional bulk techniques fall short at quantifying individual thiol/disulfide exchange reactions. Here, we adapt recently developed single-bond chemistry techniques to study individual disulfide isomerization reactions in hSOD1. Mechanical unfolding of hSOD1 leads to the formation of a polypeptide loop held by the disulfide. This loop behaves as a molecular jump rope that brings reactive Cys-111 close to the disulfide. Using force-clamp spectroscopy, we monitor nucleophilic attack of Cys-111 at either sulfur of the disulfide and determine the selectivity of the reaction. Disease-causing mutations G93A and A4V show greatly altered reactivity patterns, which may contribute to the progression of familial ALS.

Indexed as

Mutation, MissenseProtein UnfoldingAmino Acid SubstitutionAmyotrophic Lateral SclerosisCysteineDisulfidesHumansOxidation-ReductionProtein Structure, SecondarySuperoxide DismutaseSuperoxide Dismutase-1CysteineDisulfidesSOD1 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig disease)Atomic Force Microscopy (AFM)Atomic Force SpectroscopyCysteine-mediated Cross-linkingDisulfideNeurodegenerative DiseaseProtein MisfoldingSuperoxide Dismutase (SOD)

Identifiers

PMID25096579
PMCPMC4175315
OpenAlexW2041908997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.